Fox Run Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-89,236
Closed -$509K 1195
2026
Q1
$509K Buy
+89,236
New +$671K 0.09% 429
2025
Q4
Sell
-99,482
Closed -$1.06M 1152
2025
Q3
$1.06M Buy
+99,482
New +$976K 0.17% 185
2025
Q2
Sell
-10,528
Closed -$157K 1119
2025
Q1
$157K Buy
+10,528
New +$162K 0.02% 826
2024
Q4
Sell
-20,920
Closed -$400K 1089
2024
Q3
$400K Sell
20,920
-42,195
-67% -$875K 0.09% 437
2024
Q2
$1.31M Buy
63,115
+30,980
+96% +$616K 0.25% 102
2024
Q1
$604K Buy
32,135
+7,299
+29% +$125K 0.13% 296
2023
Q4
$358K Sell
24,836
-31,277
-56% -$425K 0.09% 433
2023
Q3
$974K Buy
+56,113
New +$1.17M 0.29% 80
2023
Q2
Sell
-12,587
Closed -$296K 880
2023
Q1
$296K Sell
12,587
-1,379
-10% -$37K 0.1% 407
2022
Q4
$390K Sell
13,966
-5,572
-29% -$142K 0.16% 247
2022
Q3
$457K Buy
19,538
+6,083
+45% +$184K 0.18% 203
2022
Q2
$454K Buy
+13,455
New +$471K 0.23% 155

Other funds holding OGN

Fox Run Management's OGN Position: Q2 2026 in Review

Fox Run Management sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 89,236 shares — an estimated $509K sold.

Fox Run Management first reported a position in OGN in Q2 2022 and held it in 12 quarters. The position peaked at $1.31M in Q2 2024. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Fox Run Management reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Fox Run Management sold 89,236 Organon & Co shares in Q2 2026, an estimated $509K.
  • Fox Run Management first reported a position in Organon & Co in Q2 2022 and held it in 12 quarters.
  • Fox Run Management's Organon & Co position peaked at $1.31M in Q2 2024.
  • 627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.